Literature DB >> 20639735

Attrition in cognitive-behavioral treatment of chronic back pain.

Julia Anna Glombiewski1, Jens Hartwich-Tersek, Winfried Rief.   

Abstract

OBJECTIVES: The aim of this study was to identify pretreatment factors associated with dropout from outpatient individualized cognitive-behavioral treatment for chronic back pain. Despite the importance of this issue, little is known about determinants of dropout from cognitive-behavioral treatment for chronic pain. The presented study is a subanalysis of a larger study on cognitive-behavioral treatment for chronic back pain.
METHODS: The study included 128 patients, who began a 25 session treatment. Three pretreatment domains (demographic variables, psychologic and pain-related symptom severity, and attitude toward treatment) and satisfaction with treatment within the first 3 sessions were considered as potential predictors of attrition.
RESULTS: Twenty-three patients (18%) were classified as dropouts. Low psychologic distress, low medication intake, and low treatment satisfaction were significantly associated with dropout. Other demographic variables, pain-related variables, attributions, and attitude toward treatment were not associated with treatment attrition. The associations were only valid for early dropouts. DISCUSSION: It is concluded that cognitive-behavioral treatment of chronic pain should be adapted for less psychologically distressed patients to avoid treatment dropout.

Entities:  

Mesh:

Year:  2010        PMID: 20639735     DOI: 10.1097/AJP.0b013e3181e37611

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  7 in total

Review 1.  Management of fibromyalgia syndrome in 2016.

Authors:  Akiko Okifuji; Jeff Gao; Christina Bokat; Bradford D Hare
Journal:  Pain Manag       Date:  2016-06-16

2.  If you personalize it, will they use it?: Self-reported and observed use of a tailored, internet-based pain self-management program.

Authors:  Lillian Reuman; Chelsey Solar; R Ross MacLean; Allison M Halat; Haseena Rajeevan; David A Williams; Alicia A Heapy; Matthew J Bair; Sarah L Krein; Robert D Kerns; Diana M Higgins
Journal:  Transl Behav Med       Date:  2022-05-26       Impact factor: 3.626

3.  Group interprofessional chronic pain management in the primary care setting: a pilot study of feasibility and effectiveness in a family health team in Ontario.

Authors:  Ricardo N Angeles; Dale Guenter; Lisa McCarthy; Martha Bauer; Miriam Wolfson; Maria Chacon; Lana Bullock
Journal:  Pain Res Manag       Date:  2013-07-19       Impact factor: 3.037

4.  Effects of nurse-led motivational interviewing of patients with chronic musculoskeletal pain in preparation of rehabilitation treatment (PREPARE) on societal participation, attendance level, and cost-effectiveness: study protocol for a randomized controlled trial.

Authors:  Vera-Christina Mertens; Mariëlle E J B Goossens; Jeanine A Verbunt; Albere J Köke; Rob J E M Smeets
Journal:  Trials       Date:  2013-04-02       Impact factor: 2.279

5.  Comparative efficacy of a single-session "Empowered Relief" videoconference-delivered group intervention for chronic pain: study protocol for a randomized controlled trial.

Authors:  Maisa S Ziadni; Steven R Anderson; Lluvia Gonzalez-Castro; Beth D Darnall
Journal:  Trials       Date:  2021-05-22       Impact factor: 2.279

6.  Study protocol and methods for Easing Pelvic Pain Interventions Clinical Research Program (EPPIC): a randomized clinical trial of brief, low-intensity, transdiagnostic cognitive behavioral therapy vs education/support for urologic chronic pelvic pain syndrome (UCPPS).

Authors:  Jeffrey M Lackner; James Jaccard; Brian M Quigley; Tova S Ablove; Teresa L Danforth; Rebecca S Firth; Gregory D Gudleski; Susan S Krasner; Christopher D Radziwon; Alison M Vargovich; J Quentin Clemens; Bruce D Naliboff
Journal:  Trials       Date:  2022-08-13       Impact factor: 2.728

7.  Efficacy and mechanisms of a single-session behavioral medicine class among patients with chronic pain taking prescription opioids: study protocol for a randomized controlled trial.

Authors:  Maisa S Ziadni; Abby L Chen; Tyler Winslow; Sean C Mackey; Beth D Darnall
Journal:  Trials       Date:  2020-06-12       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.